FDA approves new HIV drug from Johnson & Johnson0
- Medical News
- May 25, 2011
An exciting advancement in HIV treatment! Edurant, the name of the drug approved by the FDA, is intended for use by those individuals who have been identified as being HIV+ but have not had any medical treatment. Patients take the pill daily, and this prevents the virus from reproducing, which will reduce the levels of
READ MORE